 | • レポートコード：D005-00027 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、急性肺障害の世界市場を広く調査・分析し、今後の市場展望をまとめております。急性肺障害の種類別市場規模（薬物療法、人工呼吸、補助処置、輸液管理、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Altor BioScience、Stemedica Cell Technologies、Forschung und Entwicklung、FirstString Research、Histocell S.L.、GlaxoSmithKline、S-Evans Biosciences、CompleGen、Commence Bio、Windtree Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・急性肺障害の北米市場（アメリカ、カナダ、メキシコ） ・急性肺障害のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・急性肺障害のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・急性肺障害の南米市場（ブラジル、アルゼンチン） ・急性肺障害の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：薬物療法、人工呼吸、補助処置、輸液管理、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Acute Lung Injury market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 637.6 million by 2025, from USD 531.6 million in 2019.
The Acute Lung Injury market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Acute Lung Injury market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Acute Lung Injury market has been segmented into:
Pharmacotherapy
Mechanical Ventilation
Adjunctive Procedures
Fluid Management
Others
By Application, Acute Lung Injury has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Acute Lung Injury market presented in the report. This section sheds light on the sales growth of different regional and country-level Acute Lung Injury markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Acute Lung Injury market.
The report offers in-depth assessment of the growth and other aspects of the Acute Lung Injury market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Acute Lung Injury Market Share Analysis
Acute Lung Injury competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Acute Lung Injury sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Acute Lung Injury sales, revenue and market share for each player covered in this report.
The major players covered in Acute Lung Injury are:
Altor BioScience
Stemedica Cell Technologies
Forschung und Entwicklung
FirstString Research
Histocell S.L.
GlaxoSmithKline
S-Evans Biosciences
CompleGen
Commence Bio
Windtree Therapeutics
Table of Contents
1 Acute Lung Injury Market Overview
1.1 Product Overview and Scope of Acute Lung Injury
1.2 Classification of Acute Lung Injury by Type
1.2.1 Global Acute Lung Injury Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Acute Lung Injury Revenue Market Share by Type in 2019
1.2.3 Pharmacotherapy
1.2.4 Mechanical Ventilation
1.2.5 Adjunctive Procedures
1.2.6 Fluid Management
1.2.7 Others
1.3 Global Acute Lung Injury Market by Application
1.3.1 Overview: Global Acute Lung Injury Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Acute Lung Injury Market by Regions
1.4.1 Global Acute Lung Injury Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Acute Lung Injury (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Acute Lung Injury Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Acute Lung Injury Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Acute Lung Injury Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Acute Lung Injury Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Acute Lung Injury Status and Prospect (2015-2025)
2 Company Profiles
2.1 Altor BioScience
2.1.1 Altor BioScience Details
2.1.2 Altor BioScience Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Altor BioScience SWOT Analysis
2.1.4 Altor BioScience Product and Services
2.1.5 Altor BioScience Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.2 Stemedica Cell Technologies
2.2.1 Stemedica Cell Technologies Details
2.2.2 Stemedica Cell Technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Stemedica Cell Technologies SWOT Analysis
2.2.4 Stemedica Cell Technologies Product and Services
2.2.5 Stemedica Cell Technologies Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.3 Forschung und Entwicklung
2.3.1 Forschung und Entwicklung Details
2.3.2 Forschung und Entwicklung Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Forschung und Entwicklung SWOT Analysis
2.3.4 Forschung und Entwicklung Product and Services
2.3.5 Forschung und Entwicklung Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.4 FirstString Research
2.4.1 FirstString Research Details
2.4.2 FirstString Research Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 FirstString Research SWOT Analysis
2.4.4 FirstString Research Product and Services
2.4.5 FirstString Research Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.5 Histocell S.L.
2.5.1 Histocell S.L. Details
2.5.2 Histocell S.L. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Histocell S.L. SWOT Analysis
2.5.4 Histocell S.L. Product and Services
2.5.5 Histocell S.L. Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.7 S-Evans Biosciences
2.7.1 S-Evans Biosciences Details
2.7.2 S-Evans Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 S-Evans Biosciences SWOT Analysis
2.7.4 S-Evans Biosciences Product and Services
2.7.5 S-Evans Biosciences Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.8 CompleGen
2.8.1 CompleGen Details
2.8.2 CompleGen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CompleGen SWOT Analysis
2.8.4 CompleGen Product and Services
2.8.5 CompleGen Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.9 Commence Bio
2.9.1 Commence Bio Details
2.9.2 Commence Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Commence Bio SWOT Analysis
2.9.4 Commence Bio Product and Services
2.9.5 Commence Bio Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
2.10 Windtree Therapeutics
2.10.1 Windtree Therapeutics Details
2.10.2 Windtree Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Windtree Therapeutics SWOT Analysis
2.10.4 Windtree Therapeutics Product and Services
2.10.5 Windtree Therapeutics Acute Lung Injury Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Acute Lung Injury Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Acute Lung Injury Players Market Share
3.2.2 Top 10 Acute Lung Injury Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Acute Lung Injury Revenue and Market Share by Regions
4.2 North America Acute Lung Injury Revenue and Growth Rate (2015-2020)
4.3 Europe Acute Lung Injury Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Acute Lung Injury Revenue and Growth Rate (2015-2020)
4.5 South America Acute Lung Injury Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Acute Lung Injury Revenue and Growth Rate (2015-2020)
5 North America Acute Lung Injury Revenue by Countries
5.1 North America Acute Lung Injury Revenue by Countries (2015-2020)
5.2 USA Acute Lung Injury Revenue and Growth Rate (2015-2020)
5.3 Canada Acute Lung Injury Revenue and Growth Rate (2015-2020)
5.4 Mexico Acute Lung Injury Revenue and Growth Rate (2015-2020)
6 Europe Acute Lung Injury Revenue by Countries
6.1 Europe Acute Lung Injury Revenue by Countries (2015-2020)
6.2 Germany Acute Lung Injury Revenue and Growth Rate (2015-2020)
6.3 UK Acute Lung Injury Revenue and Growth Rate (2015-2020)
6.4 France Acute Lung Injury Revenue and Growth Rate (2015-2020)
6.5 Russia Acute Lung Injury Revenue and Growth Rate (2015-2020)
6.6 Italy Acute Lung Injury Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Acute Lung Injury Revenue by Countries
7.1 Asia-Pacific Acute Lung Injury Revenue by Countries (2015-2020)
7.2 China Acute Lung Injury Revenue and Growth Rate (2015-2020)
7.3 Japan Acute Lung Injury Revenue and Growth Rate (2015-2020)
7.4 Korea Acute Lung Injury Revenue and Growth Rate (2015-2020)
7.5 India Acute Lung Injury Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Acute Lung Injury Revenue and Growth Rate (2015-2020)
8 South America Acute Lung Injury Revenue by Countries
8.1 South America Acute Lung Injury Revenue by Countries (2015-2020)
8.2 Brazil Acute Lung Injury Revenue and Growth Rate (2015-2020)
8.3 Argentina Acute Lung Injury Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Acute Lung Injury by Countries
9.1 Middle East & Africa Acute Lung Injury Revenue by Countries (2015-2020)
9.2 Saudi Arabia Acute Lung Injury Revenue and Growth Rate (2015-2020)
9.3 UAE Acute Lung Injury Revenue and Growth Rate (2015-2020)
9.4 Egypt Acute Lung Injury Revenue and Growth Rate (2015-2020)
9.5 South Africa Acute Lung Injury Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Acute Lung Injury Revenue and Market Share by Type (2015-2020)
10.2 Global Acute Lung Injury Market Forecast by Type (2019-2024)
10.3 Pharmacotherapy Revenue Growth Rate (2015-2025)
10.4 Mechanical Ventilation Revenue Growth Rate (2015-2025)
10.5 Adjunctive Procedures Revenue Growth Rate (2015-2025)
10.6 Fluid Management Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Acute Lung Injury Market Segment by Application
11.1 Global Acute Lung Injury Revenue Market Share by Application (2015-2020)
11.2 Acute Lung Injury Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Acute Lung Injury Market Size Forecast (2021-2025)
12.1 Global Acute Lung Injury Market Size Forecast (2021-2025)
12.2 Global Acute Lung Injury Market Forecast by Regions (2021-2025)
12.3 North America Acute Lung Injury Revenue Market Forecast (2021-2025)
12.4 Europe Acute Lung Injury Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Acute Lung Injury Revenue Market Forecast (2021-2025)
12.6 South America Acute Lung Injury Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Acute Lung Injury Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Acute Lung Injury Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Acute Lung Injury by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Acute Lung Injury Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Acute Lung Injury Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Altor BioScience Corporate Information, Location and Competitors
Table 6. Altor BioScience Acute Lung Injury Major Business
Table 7. Altor BioScience Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 8. Altor BioScience SWOT Analysis
Table 9. Altor BioScience Acute Lung Injury Product and Solutions
Table 10. Altor BioScience Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Stemedica Cell Technologies Corporate Information, Location and Competitors
Table 12. Stemedica Cell Technologies Acute Lung Injury Major Business
Table 13. Stemedica Cell Technologies Acute Lung Injury Total Revenue (USD Million) (2018-2019)
Table 14. Stemedica Cell Technologies SWOT Analysis
Table 15. Stemedica Cell Technologies Acute Lung Injury Product and Solutions
Table 16. Stemedica Cell Technologies Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Forschung und Entwicklung Corporate Information, Location and Competitors
Table 18. Forschung und Entwicklung Acute Lung Injury Major Business
Table 19. Forschung und Entwicklung Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 20. Forschung und Entwicklung SWOT Analysis
Table 21. Forschung und Entwicklung Acute Lung Injury Product and Solutions
Table 22. Forschung und Entwicklung Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. FirstString Research Corporate Information, Location and Competitors
Table 24. FirstString Research Acute Lung Injury Major Business
Table 25. FirstString Research Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 26. FirstString Research SWOT Analysis
Table 27. FirstString Research Acute Lung Injury Product and Solutions
Table 28. FirstString Research Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Histocell S.L. Corporate Information, Location and Competitors
Table 30. Histocell S.L. Acute Lung Injury Major Business
Table 31. Histocell S.L. Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 32. Histocell S.L. SWOT Analysis
Table 33. Histocell S.L. Acute Lung Injury Product and Solutions
Table 34. Histocell S.L. Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Corporate Information, Location and Competitors
Table 36. GlaxoSmithKline Acute Lung Injury Major Business
Table 37. GlaxoSmithKline Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Acute Lung Injury Product and Solutions
Table 40. GlaxoSmithKline Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. S-Evans Biosciences Corporate Information, Location and Competitors
Table 42. S-Evans Biosciences Acute Lung Injury Major Business
Table 43. S-Evans Biosciences Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 44. S-Evans Biosciences SWOT Analysis
Table 45. S-Evans Biosciences Acute Lung Injury Product and Solutions
Table 46. S-Evans Biosciences Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. CompleGen Corporate Information, Location and Competitors
Table 48. CompleGen Acute Lung Injury Major Business
Table 49. CompleGen Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 50. CompleGen SWOT Analysis
Table 51. CompleGen Acute Lung Injury Product and Solutions
Table 52. CompleGen Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Commence Bio Corporate Information, Location and Competitors
Table 54. Commence Bio Acute Lung Injury Major Business
Table 55. Commence Bio Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 56. Commence Bio SWOT Analysis
Table 57. Commence Bio Acute Lung Injury Product and Solutions
Table 58. Commence Bio Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Windtree Therapeutics Corporate Information, Location and Competitors
Table 60. Windtree Therapeutics Acute Lung Injury Major Business
Table 61. Windtree Therapeutics Acute Lung Injury Total Revenue (USD Million) (2017-2018)
Table 62. Windtree Therapeutics SWOT Analysis
Table 63. Windtree Therapeutics Acute Lung Injury Product and Solutions
Table 64. Windtree Therapeutics Acute Lung Injury Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Acute Lung Injury Revenue (Million USD) by Players (2015-2020)
Table 66. Global Acute Lung Injury Revenue Share by Players (2015-2020)
Table 67. Global Acute Lung Injury Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Acute Lung Injury Revenue Market Share by Regions (2015-2020)
Table 69. North America Acute Lung Injury Revenue by Countries (2015-2020)
Table 70. North America Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Table 71. Europe Acute Lung Injury Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Acute Lung Injury Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Acute Lung Injury Revenue by Countries (2015-2020)
Table 74. South America Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Acute Lung Injury Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Table 77. Global Acute Lung Injury Revenue (Million USD) by Type (2015-2020)
Table 78. Global Acute Lung Injury Revenue Share by Type (2015-2020)
Table 79. Global Acute Lung Injury Revenue Forecast by Type (2021-2025)
Table 80. Global Acute Lung Injury Revenue by Application (2015-2020)
Table 81. Global Acute Lung Injury Revenue Share by Application (2015-2020)
Table 82. Global Acute Lung Injury Revenue Forecast by Application (2021-2025)
Table 83. Global Acute Lung Injury Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Acute Lung Injury Picture
Figure 2. Global Acute Lung Injury Revenue Market Share by Type in 2019
Figure 3. Pharmacotherapy Picture
Figure 4. Mechanical Ventilation Picture
Figure 5. Adjunctive Procedures Picture
Figure 6. Fluid Management Picture
Figure 7. Others Picture
Figure 8. Acute Lung Injury Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Acute Lung Injury Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Acute Lung Injury Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Acute Lung Injury Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Acute Lung Injury Revenue Market Share in 2019
Figure 21. Global Top 10 Players Acute Lung Injury Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Acute Lung Injury Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Acute Lung Injury Revenue Market Share by Regions (2015-2020)
Figure 25. Global Acute Lung Injury Revenue Market Share by Regions in 2018
Figure 26. North America Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 27. Europe Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 29. South America Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 31. North America Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Figure 32. North America Acute Lung Injury Revenue Market Share by Countries in 2019
Figure 33. USA Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 34. Canada Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 36. Europe Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Acute Lung Injury Revenue Market Share by Countries in 2019
Figure 38. Germany Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 39. UK Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 40. France Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 41. Russia Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 42. Italy Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Acute Lung Injury Revenue Market Share by Countries in 2019
Figure 45. China Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 46. Japan Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 47. Korea Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 48. India Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 50. South America Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Figure 51. South America Acute Lung Injury Revenue Market Share by Countries in 2019
Figure 52. Brazil Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Acute Lung Injury Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Acute Lung Injury Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 57. UAE Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Acute Lung Injury Revenue and Growth Rate (2015-2020)
Figure 60. Global Acute Lung Injury Revenue Share by Type (2015-2020)
Figure 61. Global Acute Lung Injury Revenue Share by Type in 2019
Figure 62. Global Acute Lung Injury Market Share Forecast by Type (2021-2025)
Figure 63. Global Pharmacotherapy Revenue Growth Rate (2015-2020)
Figure 64. Global Mechanical Ventilation Revenue Growth Rate (2015-2020)
Figure 65. Global Adjunctive Procedures Revenue Growth Rate (2015-2020)
Figure 66. Global Fluid Management Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Acute Lung Injury Revenue Share by Application (2015-2020)
Figure 69. Global Acute Lung Injury Revenue Share by Application in 2019
Figure 70. Global Acute Lung Injury Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Acute Lung Injury Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Acute Lung Injury Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Acute Lung Injury Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Acute Lung Injury Revenue Market Forecast (2021-2025)
Figure 78. Europe Acute Lung Injury Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Acute Lung Injury Revenue Market Forecast (2021-2025)
Figure 80. South America Acute Lung Injury Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Acute Lung Injury Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
けが応急処置スプリントの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Injury First Aid Splint market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Injury First Aid Spli…- 亜急性治療用人工呼吸器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sub-acute Care Ventilators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sub-acute Care Ven…
- 急性期医療用人工呼吸器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acute Care Ventilator market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acute Care Ventilator m…
- 急性中耳炎治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acute Otitis Media Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 2245.2 million by 2025, from USD 2013 million in 2019. The Acute Oti…
- 体外肺モデルの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global In Vitro Lung Model market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 13.6% in the forecast period of 2020 to 2025 and will expected to reach USD 281.3 million by 2025, from USD 169.1 million in 2019. The In Vitro Lung Mod…